National Bank of Canada’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-410
| Closed | -$1.34K | – | 2649 |
|
2024
Q2 | $1.34K | Buy |
410
+10
| +3% | +$33 | ﹤0.01% | 2317 |
|
2024
Q1 | $1.63K | Sell |
400
-6,600
| -94% | -$26.9K | ﹤0.01% | 2286 |
|
2023
Q4 | $25.8K | Sell |
7,000
-5,000
| -42% | -$18.5K | ﹤0.01% | 1774 |
|
2023
Q3 | $22.9K | Buy |
+12,000
| New | +$22.9K | ﹤0.01% | 1784 |
|
2023
Q1 | – | Sell |
-500
| Closed | -$5.04K | – | 2592 |
|
2022
Q4 | $5.04K | Hold |
500
| – | – | ﹤0.01% | 2165 |
|
2022
Q3 | $11K | Sell |
500
-500
| -50% | -$11K | ﹤0.01% | 1980 |
|
2022
Q2 | $25K | Buy |
+1,000
| New | +$25K | ﹤0.01% | 1800 |
|